Skip to main content
Research Article
Originally Published 7 June 2012
Free Access

Posterior Versus Anterior Circulation Infarction: How Different Are the Neurological Deficits?

Abstract

Background and Purpose—

Distinguishing between symptoms of posterior circulation infarction (PCI) and anterior circulation infarction (ACI) can be challenging. This study evaluated the frequency of symptoms/signs in the 2 vascular territories to determine the diagnostic value of particular symptoms/signs for PCI.

Methods—

Neurological deficits were reviewed and compared from 1174 consecutive patients with a diagnosis of PCI or ACI confirmed by magnetic resonance imaging in the Chengdu Stroke Registry. The diagnostic value of specific symptoms/signs for PCI was determined by measuring their sensitivity, specificity, positive predictive value (PPV), and the OR.

Results—

Homolateral hemiplegia (PCI, 53.6% versus ACI, 74.9%; P<0.001), central facial/lingual palsy (PCI, 40.7% versus ACI, 62.2%; P<0.001), and hemisensory deficits (PCI, 36.4% versus ACI, 34.2%; P=0.479) were the 3 most common symptoms/signs in PCI and ACI. The signs with the highest predictive values favoring a diagnosis of PCI were Horner's syndrome (4.0% versus 0%; P<0.001; PPV=100.0%; OR=4.00), crossed sensory deficits (3.0% versus 0%; P<0.001; PPV=100.0%; OR=3.98), quadrantanopia (1.3% versus 0%; P<0.001; PPV=100.0%; OR=3.93), oculomotor nerve palsy (4.0% versus 0%; P<0.001; PPV=100.0%; OR=4.00), and crossed motor deficits (4.0% versus 0.1%; P<0.001; PPV=92.3%; OR=36.04); however, all had a very low sensitivity, ranging from 1.3% to 4.0%.

Conclusions—

This study indicates that the symptoms/signs considered typical of PCI occur far less often than was expected. Inaccurate localization would occur commonly if clinicians relied on the clinical neurological deficits alone to differentiate PCI from ACI. Neuroimaging is vital to ensure accurate localization of cerebral infarction.

Introduction

Cerebrovascular disease, with its complex anatomy, and ischemia in different parts of the brain can produce the same neurological deficits. Because important decisions, such as revascularization, are often based on the association between symptoms and stenosis in a specific vascular territory, the clinician must be confident in the localization. Traditionally, the Oxfordshire Community Stroke Project classification used a simple clinical scheme with a high correspondence to radiological findings to distinguish posterior circulation infarction (PCI) from anterior circulation infarction (ACI).14 The presence of classic brain stem and cerebellar symptoms was used to diagnose PCI. However, this approach may not accurately localize all ischemic strokes. A substantial proportion of PCIs may not be accurately classified only by symptoms/signs, because they lack typical clinical features. Misdiagnosis usually occurs in the initial phase of patient evaluation, which may lead to erroneous clinical decision-making.
In some studies, PCI simulated involvement of the anterior circulation.58 Recent evidence from magnetic resonance imaging (MRI)-based studies demonstrated that unilateral limb weakness, unilateral limb numbness, nausea/vomiting, and headache are the major clinical neurological deficits in PCI rather than crossed paralysis, crossed sensory deficits, visual field disturbance, isolated vertigo, and dysphagia.911 This suggests that the clinical manifestations of PCI and ACI are more alike than dissimilar. A comparison of the symptoms and signs between the 2 main stroke localizations within a large series of acute stroke patients has not been performed. We compared the distribution of clinical manifestations between PCI and ACI with lesions confirmed by MRI. In addition, we tried to determine the diagnostic value of specific symptoms/signs for PCI.

Methods

Subjects

From July 2006 to May 2011, we screened 3405 patients with acute ischemic stroke admitted to the Department of Neurology, West China Hospital, located in Chengdu, China; this is a large tertiary hospital and a principal teaching affiliate of West China Medical School of Sichuan University. Consecutive patients were registered prospectively into the Chengdu Stroke Registry database, and data was collected using methods previously described.12 We excluded patients who were admitted to our hospital >2 weeks after onset (881 patients); patients without a MRI-verified ischemic lesion (337 patients); and patients with multiple infarcts involving both anterior circulation and posterior circulation, including watershed infarction (957 patients). Patients with premorbid conditions, such as previous stroke, cancer, uremia, and degenerative diseases, which could confound the neurological examination (56 patients), were also excluded. We relied on Damasio's template mapping,13 which charts the major divisions of anterior infarction, and on Bogousslavsky's standards14 to assist in classification of PCI and ACI as detailed in a previous study.15 After these exclusions, we analyzed 1174 patients and classified them into 2 groups based on infarctions involving only posterior circulation or only anterior circulation. The study was approved by the scientific research department of the hospital that conformed to the local ethical criteria during the study period.

Data Collection

Baseline information collected on admission included age, sex, admission delay, initial stroke severity (assessed using the National Institute of Health Stroke Scale and the Glasgow Coma Scale), and risk factors (atrial fibrillation, hypertension, diabetes mellitus, hyperlipidemia, current smoking, alcohol assumption, previous stroke, coronary heart disease, valvular heart disease, and myocardial infarction).
Clinical features were systematically evaluated and defined based on the American Stroke Association's published stroke warning signs and the Labiche et al study classification, with some modifications.16,17 A neurologist unaware of the imaging results performed a chart review and completed a standardized form to obtain information regarding the symptoms/signs of acute stroke and the symptoms/signs that prompted the patients to seek medical attention. Thirteen categories were classified: disturbed consciousness (confusion/delirium, somnolence, stupor, coma), speech disturbance (aphasia, dysarthria), central facial/tongue paralysis, motor or sensory deficits (mono limb; homolateral; bilateral limbs; 4 limbs and the crossed sign defined as cranial nerve findings ipsilateral, with motor and sensory findings contralateral), visual deficits (single blind, hemianopia, quadrantanopia, and diplopia), eye movement disorders (oculomotor nerve palsy, gaze palsy, nystagmus), walking instability, ataxia, seizures, syncope, Horner's syndrome, and patient complaint (vertigo, headache, nausea/vomiting, tinnitus).

Statistical Methods

Differences in demographics, risk factors, and the frequency of categorical variables between the PCI and ACI were evaluated by using t tests for continuous variables and χ2 tests for discrete variables. To assess the diagnostic value of symptoms/signs, sensitivity, and specificity, the positive predictive value (PPV) and the OR with 95% CI were calculated. Statistical analyses were carried out using the SPSS package (version 16.0 for Windows, SPSS Inc).

Results

Baseline Variables

The final adjudicated diagnoses by MRI of the 1174 patients were 872 ACI (74.3%) and 302 PCI (25.7%). Compared with ACI, patients with PCI were more often men (67.2% versus 58.0%; P=0.005), had a lower mean baseline National Institutes of Health Stroke Scale score (4.8±6.1 versus 6.5±5.9; P<0.001), and a higher mean Glasgow Coma Scale (14.3±1.9 versus 13.6±2.2; P<0.001). PCI patients had a greater frequency of diabetes (20.5% versus 13.8%; P=0.005) and smoking (39.7% versus 31.5%; P=0.009), but a lower frequency of atrial fibrillation (3.0% versus 8.7%; P=0.001) and valvular heart disease (2.0% versus 6.4%; P=0.003; Table 1).
Table 1. Demographics, Baseline NIHSS, GCS, and Risk Factors
 Posterior Circulation Infarct, No. (%)Anterior Circulation Infarct, No. (%)P Value
N302872 
Sex, men, n (%)203 (67.2)506 (58.0)0.005
Age (y) mean (SD)61.4 (14.3)62.95 (14.5)0.195
Admission Delay  0.149
    ≤3 hours11 (3.6)39 (4.5) 
    3–6 hours17 (5.6)77 (8.8) 
    >6 hours277 (90.8)757 (86.7) 
Stroke severity   
Mean NIHSS4.8 (6.1)6.5 (5.9)<0.001
Mean GCS14.3 (1.9)13.6 (2.2)<0.001
Risk factors   
    Hypertension, n (%)149 (49.3)389 (44.6)0.155
    Diabetes mellitus, n (%)62 (20.5)120 (13.8)0.005
    Hyperlipemia, n (%)20 (6.6)61 (7.0)0.826
    Coronary heart disease, n (%)9 (3.0)50 (5.7)0.059
    Myocardial infarction, n (%)4 (1.3)9 (1.0)0.921*
    Previous stroke, n (%)24 (7.9)73 (8.4)0.817
    Atrial fibrillation, n (%)9 (3.0)76 (8.7)0.001
    Valvular heart disease, n (%)6 (2.0)56 (6.4)0.003
    Current smoking, n (%)121 (39.7)275 (31.5)0.009
    Alcohol assumption, n (%)178 (20.4)74 (24.5)0.136
NIHSS indicates National Institutes of Health Stroke Scale; GCS, Glasgow Coma Scale.
*
P value obtained from Fisher exact test.

Clinical Manifestations

The frequency of each neurological deficit in both groups is presented in Table 2. Among PCI patients, disturbed consciousness at the time of hospital admission was less common (10.3% versus 18.6%; P=0.001), because at the neurological evaluation, they were less often in a somnolent or stuporous state compared with ACI patients. Concerning speech disturbances, aphasia (1.0% versus 22.0%; P=0.001) occurred in a lower percentage of PCI patients, and no statistically significant difference was found in the percent of patients having dysarthria (25.5% versus 25.0%; P=0.864) in both groups.
Table 2. Main Neurological Deficits by Infarction Localization
 Posterior Circulation Infarct, No. (%)Anterior Circulation Infarct, No. (%)P Value
N302872 
Disturbed consciousness31 (10.3)162 (18.6)0.001
    Confusion/delirium3 (1.0)25 (2.9)0.066*
    Somnolence20 (6.6)100 (11.5)0.017
    Stupor2 (0.7)29 (3.3)0.013
    Coma6 (2.0)8 (0.9)0.213*
Speech disturbance   
    Aphasia3 (1.0)192 (22.0)<0.001
    Dysarthria77 (25.5)218 (25.0)0.864
Central facial/lingual palsy123 (40.7)542 (62.2)<0.001
Motor deficits218 (72.2)749 (85.9)<0.001
    Mono limb17 (5.6)79 (9.1)0.061
    Homolateral162 (53.6)653 (74.9)<0.001
    Bilateral limbs31 (10.3)48 (5.5)0.004
    Crossed sign12 (4.0)1 (0.1)<0.001*
    Quadriplegia25 (8.3)43 (4.9)0.032
Sensory deficits140 (46.4)360 (41.3)0.124
    Mono limb15 (5.0)53 (6.1)<0.001
    Homolateral110 (36.4)298 (34.2)0.479
    Bilateral limbs6 (2.0)9 (1.0)0.203
    Crossed sign9 (3.0)0 (0)<0.001*
Visual field deficits   
    Single blind0 (0.0)2 (0.2)1.000*
    Hemianopia13 (4.3)11 (1.3)0.001
    Quadrantanopia4 (1.3)0 (0)0.005*
    Diplopia22 (7.3)6 (0.7)<0.001
Eye movement disorders   
    Oculomotor nerve palsy12 (4.0)0 (0)<0.001*
    Gaze palsy8 (2.6)96 (11.0)<0.001
    Nystagmus36 (11.9)7 (0.8)<0.001
Walking instability40 (13.2)22 (2.5)<0.001
Ataxia95 (31.5)47 (5.4)<0.001
Seizures1 (0.3)4 (0.5)1.000*
Syncope5 (1.7)29 (3.3)0.136
Horner's syndrome12 (4.0)0 (0)<0.001*
Patient complaints   
    Headache53 (17.5)83 (9.5)<0.001
    Nausea/vomiting102 (33.8)91 (10.4)<0.001
    Vertigo57 (18.9)15 (1.7)<0.001
    Tinnitus8 (2.6)8 (0.9)0.051*
*
P value obtained from Fisher exact test.
Neurological deficits that are significantly more common in PCI patients compared with ACI are shown in Figure 1. Nausea/vomiting (33.8% versus 10.4%; P<0.001) was the most frequent sign followed by ataxia (31.5% versus 5.4%; P<0.001), whereas other symptoms/signs with a low prevalence of PCI ranged from 1.3% to 18.9%.
Figure 1. Neurological deficits significantly more common in posterior circulation infarction patients.
The patients' neurological deficits in PCI and ACI were divided into 3 subgroups, using their frequency in PCI as the reference group: very common (≥30%), moderately common (10%–30%), and less common (≤10%). Homolateral paralysis (PCI, 53.6% versus ACI, 74.9%; P<0.001), central facial/lingual palsy (PCI, 40.7% versus ACI, 62.2%; P<0.001), and hemisensory deficits (PCI, 36.4% versus ACI, 34.2%; P=0.479) were the 3 most common neurological deficits in PCI and ACI; however, a large proportion of specific neurological deficits that occurred significantly more often in PCI patients were in the moderately and less common subgroups with frequency <30% (Figure 2).
Figure 2. The frequency of single clinical symptom/sign in posterior circulation infarction and anterior circulation infarction.

Predictive Value of Neurological Deficits in Diagnosing Patients With PCI

Table 3 shows the value of single neurological deficit for a PCI diagnosis. The neurological deficits with the highest predictive values favoring the diagnosis of PCI were in the less common subgroup, including Horner's syndrome (PPV=100.0%; OR=4.00), crossed sensory deficits (PPV=100.0%; OR=3.98), quadrantanopia (PPV=100.0%; OR=3.93), oculomotor nerve palsy (PPV=100.0%; OR=4.00), and crossed motor deficits (PPV= 92.3%; OR=36.04). However, all of them occurred with an extremely low sensitivity ranging from 1.3% to 4.0% of PCI patients, which means that the probability of detecting neurological deficits in patients with PCI was very low. Neurological deficits with a relatively good predictive value such as ataxia (PPV=66.9%; OR=8.06), nausea/vomiting (PPV=52.8%; OR=4.38), nystagmus (PPV=83.7%; OR=16.72), vertigo (PPV=79.2%; OR=13.29), and diplopia (PPV=78.6%; OR=11.34), also displayed low sensitivities that decreased their diagnostic value.
Table 3. Value of Single Symptom/Sign in Diagnosing Patients With PCI
Symptoms/SignsNo. of PatientsNo. With PCISensitivity (%)Specificity (%)Positive Predictive Value (%)OR (95% CI)
N1174302    
The very common subgroup      
    Homolateral paralysis815 (69.4)16253.625.119.90.39 (0.29–0.51)
    Central facial/tongue paralysis665 (56.5)12340.737.818.50.42 (0.32–0.55)
    Hemisensory deficits408 (34.8)11036.465.827.01.10 (0.84–1.45)
    Nausea/vomiting193 (16.4)10233.889.652.84.38 (3.17–6.04)
    Ataxia142 (12.1)9531.594.666.98.06 (5.50–11.80)
The moderately common subgroup      
    Dysarthria295 (25.1)7725.575.026.11.03 (0.76–1.39)
    Vertigo72 (6.1)5718.998.379.213.29 (7.40–23.89)
    Headache136 (11.6)5317.590.539.02.02 (1.39–2.94)
    Walking instability62 (5.3)4013.297.564.55.90 (3.44–10.12)
    Nystagmus43 (3.7)3611.999.283.716.72 (7.36–38.02)
    Disturbed consciousness193 (16.4)3110.381.416.10.50 (0.33–0.76)
    Bilateral motor weakness79 (6.7)3110.394.539.21.96 (1.23–3.15)
The less common subgroup      
    Quadriplegia68 (5.8)258.395.136.81.74 (1.04–2.90)
    Diplopia28 (2.4)227.399.378.611.34 (4.55–28.25)
    Mono limb weakness95 (8.1)175.691.117.90.61 (0.35–1.04)
    Hemianopia24 (2.0)134.398.754.23.52 (1.56–7.95)
    Horner's syndrome12 (1.0)124.0100.0100.04.00 (3.63–4.43)
    Oculomotor nerve palsy12 (1.0)124.0100.0100.04.00 (3.63–4.43)
    Crossed motor deficits13 (1.1)124.099.992.336.04 (4.67–278.38)
    Crossed sensory deficits9 (0.8)93.0100.0100.03.98 (3.60–4.39)
    Tinnitus16 (1.4)82.699.150.02.94 (1.10–7.90)
    Gaze palsy104 (8.9)82.689.07.70.22 (0.11–0.46)
    Bilateral sensory deficits15 (1.3)62.099.040.01.94 (0.69–5.51)
    Syncope34 (2.9)51.796.714.70.49 (0.19–1.28)
    Quadrantanopia4 (0.3)41.3100.0100.03.93 (3.56–4.33)
    Aphasia195 (16.6)31.078.11.50.04 (0.01–0.11)
    Seizures5 (0.4)10.399.520.00.72 (0.08–6.48)
PCI indicates posterior circulation infarction.

Discussion

Given the limited information deriving from small case series with highly selected PCI patients, as well as the low performance rate of MRI in these studies, there have not been reliable clinical criteria for PCI. In the current study, we initially compared the frequency of neurological deficits between the 2 groups and found a similar distribution among the most common symptoms and signs between PCI and ACI. Second, we assessed the ability of a single neurological deficit to discriminate PCI from ACI, and we observed that despite some symptoms and signs having approximately 100% specificity for diagnosing PCI, symptoms/signs with a higher predictive value had a very low prevalence. These findings emphasize the fact that the clinical manifestations between PCI and ACI have a high degree of similarity.
In this study, we observed that the most common neurological deficits were homolateral paralysis, central facial/lingual palsy, and hemisensory deficits in PCI; and also, that these were the 3 most common in ACI. Previous studies, the New England Medical Center Posterior Circulation Registry, and a Qatar study presented within-study comparisons of the frequency of the neurological deficits in PCI cohorts; but, these studies did not compare PCI with ACI patients.11,18 The frequency appeared to vary in some clinical manifestations in these previous studies, as compared with that in our study; however, homolateral paralysis and facial palsy were also found previously to be the most common signs in PCI patients. The divergent frequencies may partly caused by differences in the severity of vertebrobasilar ischemia among stroke populations11 and the different definitions studies used when classifying the neurological deficits. In a series of articles from the New England Medical Center Posterior Circulation Registry, Caplan et al reported that unilateral limb weakness (38%) was the most frequent sign in the whole PCI cohort, hemiparesis and tetraparesis (62%) were the most common signs for patients with midbrain infarction, and hemiparesis was present in more than half of patients (50.6%), along with basilar artery occlusive disease.11,19,20 Furthermore, in a study that analyzed the clinical manifestations of pontine infarction, pure motor hemiparesis or hemiplegia was found in a large proportion of patients instead of classical crossed syndromes, and cannot be distinguished from the internal capsule-corona radiata region infarctions by clinical signs alone.21 These findings are consistent with our view that PCI patients with homolateral paralysis are common in clinical practice.
Besides the nonspecificity of most clinical manifestations in PCI versus ACI, we should also emphasize that there are still certain symptoms/signs favoring a diagnosis of PCI, such as crossed motor/sensory deficits, oculomotor nerve palsy, visual field deficits, and Horner's syndrome, which are highly suggestive. Another point to consider is that these signs occurred infrequently (<10%); hence, it is difficult to identify most PCI patients based on these relatively rare clinical manifestations. One previous study with the observation that approximately 10% to 20% of patients with a diagnosis of presumed ACI actually have a PCI supports our contention.8 The misdiagnosis rate in the previous study might be underestimated because of the small number of patients included and the low sensitivity of computed tomography in detecting multiple infarctions involving the posterior fossa.
According to the literature, crossed signs such as ipsilateral motor and sensory cranial nerve signs or symptoms plus contralateral hemiplegia or hemianaesthesia are specific symptoms that point to brain stem involvement.22 However, in the present cohorts, crossed motor deficits occurred infrequently (13 patients; 1.1%), with only 1 patient diagnosed with ACI having MRI-confirmed bilateral middle cerebral artery infarction that happened suddenly after cholecystectomy. Crossed sensory deficits occurred in only 9 PCI patients (3.0%) and in 0 patients with ACI. The crossed sensory deficits correlated well with lesion locations involving the medulla, whereas crossed motor deficits were associated with lesions in medulla (n=8), pons (n=2), and midbrain (n=2). A study focusing on pure lateral medullary infarction reported that the rate of the crossed sensory deficits was high at approximately 26%,23 but the correlation between infarct topography and the crossed motor/sensory signs in PCI patients were not well-described and need additional investigation.
Contrary to current belief, our results do not support the conventional wisdom that holds that disturbed consciousness is highly specific for PCI. Since the initial description of the clinical findings in a small group of select patients with brain stem infarction by Kubik and Adams,24 disturbances of consciousness were considered to be an important feature of PCI. This was followed by studies of patients with specific vertebrobasilar lesions, including the midbrain, cerebellum, and basilar artery occlusive disease separately; the rate of disturbed consciousness was high, frequently >20%.20,2527 In the most extensive of these studies, Carol et al reported 20 patients with basilar artery occlusion and found 19 of them had various impairment of consciousness.27 In contrast, Sato et al reported a much lower rate of disturbed consciousness in patients with PCI than with ACI (18% versus 41%; P<0.001); this was in accordance with our cohorts that disturbed consciousness accompanied with a corresponding lower Glasgow Coma Scale score occurred in 10.3% of PCI, which was less prevalent than that in ACI (18.6%).28 Similarly, 2 recent studies showed that the prevalence of altered level of consciousness in PCI patients was much lower (<10% and 18%, respectively) than was suggested by previous studies.11,18 These controversies might be caused by a different distribution of stroke subtypes or different age groups. At the least, the present study revealed that additional investigations are required to determine whether consciousness disturbance should be considered diagnostic for PCI.
In the present study, nausea/vomiting, vertigo, and headaches were found to be the symptoms that occur more frequently in patients with PCI. Because circulation to the inner ear arises from the vertebrobasilar system, vertebral-artery disease can cause vertigo that is usually accompanied by other brain stem or cerebellar symptoms.29 A previous study emphasized that isolated vertigo is rarely attributable to vascular events and it was in accordance with our findings that only 4 patients with PCI had isolated vertigo.30
We are aware of the limitations of the present study. First, to elaborate the clinical features of pure PCI and ACI, we excluded patients with multiple lesions involving both posterior circulation and anterior circulation without MRI confirmation; this may have resulted in a selection bias. Second, the delineation of clinical symptoms and signs was completely dependent on chart review, and thus, the authors were unable to confirm rare manifestations. Nonetheless, most of the medical charts within the present study contained high-quality data. Third, as a hospital-based study, subjects who experienced more severe or minor stroke were not admitted to the hospital, although this hospital is the largest one in the region. Given the large sample and statistical significance of the observed effects in the present study, these limitations are unlikely to affect the results.

Conclusion

In this observational study, we found that there was no apparent difference in the frequency of the most common symptoms/signs between PCI and ACI. Some neurological deficits were highly specific for diagnosing PCI, but their sensitivity suggests that symptoms or signs considered typical of PCI are uncommon. Inaccurate localization would be common if clinicians only relied on clinical symptoms/signs to differentiate PCI from ACI, and this observation suggests that neuroimaging findings, particularly MRI, are vital for accurate localization.

Acknowledgments

The authors would like to acknowledge their gratitude to Dr Matthew S. Siket and Dr Lorenzano Svetlana for their valuable comments on this manuscript.

Sources of Funding

This work was funded by Science and Technology Department of Sichuan Province of China (Project No. 2011SZ0202).

References

1.
Lindley RI, Warlow CP, Wardlaw JM, Dennis MS, Slattery J, Sandercock PA. Interobserver reliability of a clinical classification of acute cerebral infarction. Stroke. 1993;24:1801–1804.
2.
Aerden L, Luijckx GJ, Ricci S, Hilton A, Kessels F, Lodder J. Validation of the Oxfordshire Community Stroke Project syndrome diagnosis derived from a standard symptom list in acute stroke. J Neurol Sci. 2004;220:55–58.
3.
Wardlaw JM, Dennis MS, Lindley RI, Sellar RJ, Warlow CP. The validity of a simple clinical classification of acute ischaemic stroke. J Neurol. 1996;243:274–279.
4.
Mead GE, Lewis SC, Wardlaw JM, Dennis MS, Warlow CP. How well does the Oxfordshire Community Stroke Project classification predict the site and size of infarct on brain imaging? J Neurol Neurosurg Psychiatry. 2002;68:558–562.
5.
Nighoghossian N, Ryvlin P, Trouillas P, Laharotte JC, Froment JC. Pontine versus capsular pure motor hemiparesis. Neurology. 1993;43:2197–2201.
6.
Chambers BR, Brooder RJ, Donnan GA. Proximal posterior cerebral artery occlusion simulating middle cerebral artery occlusion. Neurology. 1991;41:385–390.
7.
Hommel M, Besson G, Pollak P, Kahane P, Le Bas JF, Perret J. Hemiplegia in posterior cerebral artery occlusion. Neurology. 1990;40:1496–1499.
8.
Argentino C, De Michele M, Fiorelli M, Toni D, Sacchetti ML, Cavalletti C, et al. Posterior circulation infarcts simulating anterior circulation stroke. Perspective of the acute phase. Stroke. 1996;27:1306–1309.
9.
Shi GW, Xiong XL, Lin Y, Li YS. [The clinical characteristics of patients with posterior circulation ischemic stroke]. Zhonghua Nei Ke Za Zhi. 2008;47:393–396.
10.
Fan FQ, Liu MP, Liu ZH, Wang CM. Investigation of Clinical Manifestation and Magnetic Resonance in Patients with Posterior Circulation Infarction. Chin J Stroke. 2010;5:730–734.
11.
Searls DE, Pazdera L, Korbel E, Vysata O, Caplan LR. Symptoms and signs of posterior circulation ischemia in the new England medical center posterior circulation registry. Arch Neurol. 2012;69:346–351.
12.
Kong FY, Tao WD, Hao ZL, Liu M. Predictors of one-year disability and death in Chinese hospitalized women after ischemic stroke. Cerebrovasc Dis. 2010;29:255–262.
13.
Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol. 1983;40:138–142.
14.
Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50:1699–1708.
15.
Tao WD, Kong FY, Hao ZL, Lin S, Wang DR, Wu B, et al. One-year case fatality and disability after posterior circulation infarction in a Chinese hospital-based stroke study. Cerebrovasc Dis. 2010;29:376–381.
16.
Learn to recognize stroke. Available at: http//www.Strokeassociation.Org/presenter.Jhtml?Identifier=1020. Accessed December 10, 2008.
17.
Labiche LA, Chan W, Saldin KR, Morgenstern LB. Sex and acute stroke presentation. Ann Emerg Med. 2002;40:453–460.
18.
Akhtar N, Kamran SI, Deleu D, D'Souza A, Miyares F, Elsotouhy A, et al. Ischaemic posterior circulation stroke in State of Qatar. European Journal of Neurology. 2006;16:1004–1009.
19.
Martin PJ, Chang HM, Wityk R, Caplan LR. Midbrain infarction: associations and aetiologies in the New England Medical Center Posterior Circulation Registry. J Neurol Neurosurg Psychiatry. 1998;64:392–395.
20.
Voetsch B, DeWitt LD, Pessin MS, Caplan LR. Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol. 2004;61:496–504.
21.
Ling L, Zhu L, Zeng J, Liao S, Zhang S, Yu J, et al. Pontine infarction with pure motor hemiparesis or hemiplegia: a prospective study. BMC Neurology. 2009;9:25–33.
22.
Sinha KK. Brain stem infarction: clinical clues to localise them. Indian Academy of Clinical Medicine. 2000;1:213–221.
23.
Kim JS. Pure lateral medullary infarction: clinical-radiological correlation of 130 acute, consecutive patients. Brain. 2003;126:1864–1872.
24.
Kubik CS, Adams RD. Occlusion of the basilar artery; a clinical and pathological study. Brain. 1946;69:73–121.
25.
Tohgi H, Takahashi S, Chiba K, Hirata Y. Cerebellar infarction. Clinical and neuroimaging analysis in 293 patients. The Tohoku Cerebellar Infarction Study Group. Stroke. 1993;24:1697–1701.
26.
Kumral E, Bayulkem G, Akyol A, Yunten N, Sirin H, Sagduyu A. Mesencephalic and associated posterior circulation infarcts. Stroke. 2002;33:2224–2231.
27.
Archer CR, Horenstein S. Basilar artery occlusion: clinical and radiological correlation. Stroke. 1977;8:383–390.
28.
Sato S, Toyoda K, Uehara T, Toratani N, Yokota C, Moriwaki H, et al. Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology. 2008;70:2371–2377.
29.
Lee CC, Su YC, Ho HC, Hung SK, Lee MS, Chou P, et al. Risk of stroke in patients hospitalized for isolated vertigo: a four-year follow-up study. Stroke. 2011;42:48–52.
30.
Savitz SI, Caplan LR. Vertebrobasilar disease. N Engl J Med. 2005;352:2618–2626.

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Stroke
Stroke
Pages: 2060 - 2065
PubMed: 22678088

Versions

You are viewing the most recent version of this article.

History

Received: 2 February 2012
Accepted: 26 April 2012
Published online: 7 June 2012
Published in print: August 2012

Permissions

Request permissions for this article.

Keywords

  1. posterior circulation infarction
  2. anterior circulation infarction
  3. neurological deficits

Subjects

Authors

Affiliations

Wen-Dan Tao, MD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Ming Liu, MD, PhD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Marc Fisher, MD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
De-Ren Wang, MD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Jie Li, MD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Karen L Furie, MD, MPH
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Zi-Long Hao, MD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Sen Lin, MD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Can-Fei Zhang
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Quan-Tao Zeng
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.
Bo Wu, MD, PhD
From the Stroke Clinical Research Unit, Department of Neurology (W.D.T., M.L., D.R.W., J.L., Z.L.H., S.L., C.F.Z., Q.T.Z., B.W.) and State Key Laboratory of Biotherapy and Cancer Center (M.L.), West China Hospital, Sichuan University; the J. Philip Kistler Stroke Research Center (W.D.T., K.L.F.), Department of Neurology, Massachusetts General Hospital, Boston, MA; and the Department of Neurology (M.F.), University of Massachusetts Medical School, Worcester, MA.

Notes

Jeffrey L. Saver, MD, was the Guest Editor for this article.
Correspondence to Professor Ming Liu, Stroke Clinical Research Unit, Department of Neurology, West China Hospital, Sichuan University, No 37, Guo Xue Xiang, Chengdu, 610041, Sichuan Province, P R China. E-mail [email protected]

Disclosures

None.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Area postrema syndrome as the only sign of medullary infarction adjacent to area postrema, eNeurologicalSci, 39, (100563), (2025).https://doi.org/10.1016/j.ensci.2025.100563
    Crossref
  2. Tratamiento endovascular del ictus isquémico vertebrobasilar en Aragón: características clínicas, radiológicas, tiempos de atención y pronóstico a los 3 meses, Neurología, 40, 3, (239-248), (2025).https://doi.org/10.1016/j.nrl.2023.02.001
    Crossref
  3. Using HINTS in acute vestibular syndrome: A practical guide for the acute care physician, Journal of the Royal College of Physicians of Edinburgh, (2025).https://doi.org/10.1177/14782715251325585
    Crossref
  4. Endovascular treatment of vertebrobasilar ischaemic stroke in Aragon: clinical and radiological characteristics, management times, and prognosis at 3 months, Neurología (English Edition), (2025).https://doi.org/10.1016/j.nrleng.2025.03.004
    Crossref
  5. Perfusion patterns as a tool for emergency stroke diagnosis: differentiating proximal and distal MCA occlusions, BMJ Neurology Open, 7, 1, (e001001), (2025).https://doi.org/10.1136/bmjno-2024-001001
    Crossref
  6. Symptoms, Imaging Features, Treatment Decisions, and Outcomes of Patients with Top of the Basilar Artery Syndrome: Experiences from a Comprehensive Stroke Center, Neurocritical Care, (2025).https://doi.org/10.1007/s12028-025-02219-y
    Crossref
  7. Cerebellar control of targeted tongue movements, The Journal of Physiology, 603, 5, (1141-1169), (2025).https://doi.org/10.1113/JP287732
    Crossref
  8. Surgical outcomes of subclavian steal syndrome combined with carotid artery stenosis: A single-center retrospective observational study, Science Progress, 108, 1, (2025).https://doi.org/10.1177/00368504241307470
    Crossref
  9. End-to-end deep learning patient level classification of affected territory of ischemic stroke patients in DW-MRI, Neuroradiology, 67, 1, (137-151), (2024).https://doi.org/10.1007/s00234-024-03520-x
    Crossref
  10. Clinical characteristic and long-term prognosis in vertebrobasilar stroke, Russian neurological journal, 29, 4, (54-61), (2024).https://doi.org/10.30629/2658-7947-2024-29-4-54-61
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Posterior Versus Anterior Circulation Infarction
Stroke
  • Vol. 43
  • No. 8

Purchase access to this journal for 24 hours

Stroke
  • Vol. 43
  • No. 8
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Figures

Tables

Media

Share

Share

Share article link

Share

Comment Response